Estradiol Immunoaffinity HPLC Column

The Estradiol Immunoaffinity HPLC Column is For Research Use Only

Size: 3ml, 10 columns

Assay Principle

Many methods of Estrogens determination based on HPLC-UV detection show low selectivity if problematic matrices are applied. This method of content determination of Estrogens combines the high selectivity of immunoaffinity columns with its high potential to concentrate elute and of purification by HPLC column. The following instruction gives an optimized protocol for enrichment of very low contents in the pg/g range. In this case a mass detector might be best suited.

Please notice, that this instruction focuses on the handling with the IAC column. The given apparatus and detection (e.g. HPLC-FLD system) might serve as example among other possibilities.

---

Sample Preparation:
Sewage and drinking water samples are collected as described by Quintana et al1. Raw samples may be filtered through a 0.45μm pore size cellulose filter. Example: 1000g sewage effluent sample (equals approximately 1L) firstly are filtered like mentioned before and then added to the filtrate 10ml Buffer Solution (see under Buffer and Chemicals) to maintain pH neutrality. Thus, the final sample contains 1% (v/v) Buffer Solution.

---

Related Products

Folic Acid Immunoaffinity Column
Fumonisin Immunoaffinity Column
Biotin Immunoaffinity Column
Product Developed and Manufactured in Germany by BioTeZ Berlin-Buch GmbH

EagleBio的5α-雄甾烷-3α，17β-二醇葡糖醛酸化物是C19类固醇，缩写为3α-DiolG，5α二醇G或简称为α二醇G。它主要作为睾丸激素和二氢睾丸激素（DHT）的代谢产物生产。它主要在目标外围组织（例如皮肤）中产生，尤其是在毛囊周围。大量的3α-DiolG刺激会导致过多的头发形成，特别是在女性通常不存在头发的地方。近年来，在研究患有特发性多毛症的妇女的临床研究人员中，人们对这种类固醇的测量越来越感兴趣。已知是3α-DiolG前体的类固醇包括脱氢表雄酮（DHEA），硫酸脱氢表雄酮（DHEAS），二氢睾丸酮（DHT），雄烯二酮和睾丸激素。已显示只有3α-DiolG随多毛症增加而随治疗减少。这种相关性在多囊卵巢综合征（PCO）患者中也得到了证明。3α-DiolG的测定因此被证明是多种方式的有用指标，包括监测特发性多毛症和PCO妇女的治疗进展。此外，接受环孢霉素A治疗的糖尿病患者（无论男女）均显示3α-DiolG水平升高，这种副作用导致以前无毛的区域出现了头发。3α-DiolG的测定因此被证明是多种方式的有用指标，包括监测特发性多毛症和PCO妇女的治疗进展。此外，接受环孢霉素A治疗的糖尿病患者（无论男女）均显示3α-DiolG水平升高，这种副作用导致以前无毛的区域出现了头发。3α-DiolG的测定因此被证明是多种方式的有用指标，包括监测特发性多毛症和PCO妇女的治疗进展。此外，接受环孢霉素A治疗的糖尿病患者（无论男女）均显示3α-DiolG水平升高，这种副作用导致以前无毛的区域出现了头发。